Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 2 randomized trials
Authors
Eriksson BI, Dahl OE, Rosencher N, Clemens A, Hantel S, Feuring M, Kreuzer J, Friedman RJ, Huo M
Journal
Thromb J
Publication Date
2015
Impact Factor
1.240
Abstract
Additional IDs
Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 2 randomized trials - Publication by Dr. Andreas Clemens | Dr. Andreas Clemens